Jin Yang Pharmaceutical Co. Ltd
Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports i… Read more
Jin Yang Pharmaceutical Co. Ltd (007370) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.013x
Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.64 Billion) by net assets (₩127.68 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jin Yang Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ekarat Engineering Public Company Limited
BK:AKR
|
0.103x |
|
Victory New Materials Ltd Co
TW:1340
|
-0.003x |
|
Eniro AB
ST:ENRO
|
0.039x |
|
Chiho Environmental Group Limited
STU:T4N
|
-0.017x |
|
SHL Consolidated Bhd
KLSE:6017
|
0.026x |
|
Globaltec Formation Bhd
KLSE:5220
|
0.056x |
|
HORNG SHIUE HOLDING Co Ltd
TW:2243
|
-0.071x |
|
American Creek Resources Ltd
OTCQB:ACKRF
|
-0.114x |
Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩119.88 Billion | ₩12.79 Billion | 0.107x | +12.02% |
| 2023-12-31 | ₩89.58 Billion | ₩8.53 Billion | 0.095x | -0.78% |
| 2022-12-31 | ₩77.58 Billion | ₩7.45 Billion | 0.096x | +218.24% |
| 2021-12-31 | ₩65.32 Billion | ₩1.97 Billion | 0.030x | -77.63% |
| 2020-12-31 | ₩46.31 Billion | ₩6.24 Billion | 0.135x | -18.33% |
| 2019-12-31 | ₩43.67 Billion | ₩7.21 Billion | 0.165x | +555.78% |
| 2018-12-31 | ₩42.05 Billion | ₩1.06 Billion | 0.025x | +208.08% |
| 2017-12-31 | ₩42.38 Billion | ₩-987.16 Million | -0.023x | -8399.26% |
| 2016-12-31 | ₩49.15 Billion | ₩-13.47 Million | 0.000x | +99.41% |
| 2015-12-31 | ₩59.18 Billion | ₩-2.76 Billion | -0.047x | +7.06% |
| 2014-12-31 | ₩61.48 Billion | ₩-3.08 Billion | -0.050x | -- |